Paulina Merino, Codner E. CONTRACEPTION FOR ADOLESCENTS AND YOUNG WOMEN WITH TYPE 2 DIABETES-SPECIFIC CONSIDERATIONS” Curr Diab Rep 2022; 22: 77-84.

Harnois-Leblanc S, Hernandez MI, Codner E, Cassorla F, Oberfield SE, Leibel NI, Mathew RP, Ten S, Magoffin DA, Lane CJ, Goran MI, Azziz R, Baillargeon JP, Geller DH.
“PROFILE OF DAUGHTERS AND SISTERS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME: THE ROLE OF PROBAND'S GLUCOSE TOLERANCE”. The Journal of Clinical Endocrinology & Metabolism, 2022, Vol. 107, No. 3, e912–e923

Franco Giraudo, Ignacio Lalanne, Ismael Valdés, Abraham Gajardo, Denise Charron-Prochownik, Ethel Codner. “RISKY SEXUAL BEHAVIORS IN ADOLESCENTS AND YOUNG ADULT WOMEN WITH TYPE 1 DIABETES: AN OVERLOOKED PROBLEM” Pediatr Diabetes. 2021; 22:1092–1098.

Dra. Maria Lina Boza C., Dr. Joel Melo T., Dra. Salesa Barja Y., Dra. Ethel Codner D., Klgo Patricio Gomolan G., QFC Rubén Hernández M., Dr. Luis Astorga F., Dra. Hortensia Barrientos I., Dr. Rodrigo Bozzo H., Dr. Mauricio Calderón R., Nut. Jeanette Cáceres V., Dr. Eduardo Chávez C., Dra. Ilse Contreras E., Dra. María Teresita Henríquez Y., Dr. Oscar Fielbaum C., Dra. Leticia Jakubson S., EU Beatriz Jara H., Dr. Pablo Jorquera P., Dr. Ricardo Kogan A., Dra. Viviana Lezana S., Klgo. Rodolfo Meyer P., Dr. Francisco Moraga M., Klgo Gustavo Moscoso G., Dra. Elizabeth Navarro D., EU María de los Ángeles Orellana F., Dra. Genoveva Parra O., Dra. Daniela Pavez A., Dra. María Eugenia Pérez O., EU María José Pinochet N., Klgo. Homero Puppo G., EU Ana Isabella Quintanilla A., Dra. Gabriela Repetto L., EU Lisset Slaibe C., Dr. Julio Soto B., EU Adriana Vega M., Dra. Carolina Wong L. “CONSENSO CHILENO PARA LA ATENCIÓN INTEGRAL DE NIÑOS Y ADULTOS CON FIBROSIS QUÍSTICA”. Neumol Pediatr 2020; 15 (4): 429 - 483

Codner E. “METABOLIC PROBLEMS IN THE OFFSPRING OF WOMEN WITH GESTATIONAL DIABETES AND OBESITY: AN OPPORTUNITY FOR PREVENTION”. J Clin Endocrinol Metab 2020;105.

Codner E. “TYPE 1 DIABETES, OBESITY AND PCOS: IS TYPE 1 STEPPING INTO THE SHOES OF TYPE 2 DIABETES?” Clin Endocrinol (Oxf) 2020.

Codner E, Cerda T, Gaete X. “PUBERTY IN TYPE 1 DIABETES MELLITUS: ADVANCES IN CARE ARE ASSOCIATED WITH CHANGES IN PUBERTAL MILESTONES AND HORMONE PROFILES”. Current Opinion in Endocrine and Metabolic Research 2020;14:85-91.

Dhatariya KK, Glaser NS, Codner E, Umpierrez GE. “DIABETIC KETOACIDOSIS”.
Nat Rev Dis Primers 2020;6:40.

Priyambada L, Wolfsdorf JI, Brink SJ, Fritsch M, Codner E, Donaghue KC, Craig ME.
“ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINE: DIABETIC KETOACIDOSIS IN THE TIME OF COVID-19 AND RESOURCE-LIMITED SETTINGS-ROLE OF SUBCUTANEOUS INSULIN”. Pediatr Diabetes 2020.

Salinas A, Merino PM, Giraudo F, Codner E. “LONG-ACTING CONTRACEPTION IN ADOLESCENTS AND YOUNG WOMEN WITH TYPE 1 AND TYPE 2 DIABETES”. Pediatr Diabetes 2020.

Thong EP, Codner E, Laven JSE, Teede H. DIABETES: A METABOLIC AND REPRODUCTIVE DISORDER IN WOMEN”. Lancet Diabetes Endocrinol 2020;8:134-149.

Nicolas Crisosto, Ph.D., M.D., Amanda Ladron de Guevara, M.D., Barbara Echibur, M.Sc., Manuel Maliqueo, Ph.D., Gabriel Cavada, Ph.D., Ethel Codner, M.D., Francisco Paez, M.D., and Teresa Sir-Petermann, Ph.D., M.D. “HIGHER LUTEINIZING HORMONE LEVELS ASSOCIATED WITH ANTIMÜLLERIAN HORMONE IN POSTMENARCHAL DAUGHTERS OF WOMEN WITH POLYCYSTIC OVARY SYNDROME”. Fertility and Sterility 2019; 111:381-388.

Paulina M. Merino MD, Patricia Lopez B, Abril Salinas MD, PhD, Carolina Pastene MD, Alex Muñoz BS, Fernando Cassorla MD, Ethel Codner MD “OVARIAN FUNCTION IN ADOLESCENTS CONCEIVED USING ASSISTED REPRODUCTIVE TECHNOLOGIES” J Pediatr Adolesc Gynecol 32 (2019) 117e121

Pamela Bowman, Åsta Sulen, Fabrizio Barbetti, Jacques Beltrand, Pernille Svalastoga, Ethel Codner, Ellen H Tessmann, Petur B Juliusson, Torild Skrivarhaug, Ewan R Pearson, Sarah E Flanagan, Tarig Babiker, Nicholas J Thomas, Maggie H Shepherd, Sian Ellard, Iwar Klimes, Magdalena Szopa, Michel Polak, Dario Iafusco, Andrew T Hattersley†, Pål R Njølstad†, for the Neonatal Diabetes International Collaborative Group‡ “EFFECTIVENESS AND SAFETY OF LONG-TERM TREATMENT WITH SULFONYLUREAS IN PATIENTS WITH NEONATAL DIABETES DUE TO KCNJ11 MUTATIONS: AN INTERNATIONAL COHORT STUDY” The Lancet Diabetes & Endocrinology 2018. Published online June 4, 2018 http://dx.doi.org/10.1016/S2213-8587(18)30106-2

D. F. Garcia-Diaz, P. Camacho-Guillén, E. Codner, F. Pérez-Bravo “MIR15A AND MIR16 IN CHILEAN TYPE 1 DIABETES PATIENTS: POSSIBLE ASSOCIATION WITH APOPTOSIS, INLAMMATORY, OR AUTOIMMUNITY MARKERS” Journal of Endocrinological Investigation Received: 17 March 2017 / Accepted: 22 December 2017 Italian Society of Endocrinology (SIE) 2018

Diego F. García-Díaz, Carolina Pizarro, Patricia Camacho-Guillén, Ethel Codner, Néstor Soto, Francisco Pérez-Bravo “EXPRESSION OF MIR-155, MIR-146A, AND MIR-326 IN T1D PATIENTS FROM CHILE: RELATIONSHIP WITH AUTOIMMUNITY AND INFLAMMATORY MARKERS” Arch Endocrinol Metab. 2018; 62:34-40.

Cameron FJ, Garvey K, Hood KK, Acerini CL, Codner E. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: DIABETES IN ADOLESCENCE”. Pediatr Diabetes 2018; 19 Suppl 27:250-261.

Codner E, Acerini C, Craig ME, Hofer S, Maahs DM. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: INTRODUCTION TO THE LIMITED CARE GUIDANCE APPENDIX”. Pediatr Diabetes 2018; 19 Suppl 27:326-327.
Codner E, Acerini CL, Craig ME, Hofer SE, Maahs DM. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: WHAT IS NEW IN DIABETES CARE?” Pediatr Diabetes 2018; 19 Suppl 27:5-6.

Codner E, Acerini CL, Craig ME, Hofer SE, Maahs DM. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: LIMITED CARE GUIDANCE APPENDIX”. Pediatr Diabetes 2018; 19 Suppl 27:328-338.

Danne T, Phillip M, Buckingham BA, Jarosz-Chobot P, Saboo B, Urakami T, Battelino T, Hanas R, Codner E. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: INSULIN TREATMENT IN CHILDREN AND ADOLESCENTS WITH DIABETES”. Pediatr Diabetes 2018;19 Suppl 27:115-135.

DiMeglio LA, Acerini CL, Codner E, Craig ME, Hofer SE, Pillay K, Maahs DM. “ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: GLYCEMIC CONTROL TARGETS AND GLUCOSE MONITORING FOR CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH DIABETES”. Pediatr Diabetes 2018;19 Suppl 27:105-114.

Villarroel C, Salinas A, Lopez P, Kohen P, Rencoret G, Devoto L, Codner E. “ANTI-MULLERIAN HORMONE IN TYPE 2 AND GESTATIONAL DIABETES DURING THE SECOND HALF OF PREGNANCY: RELATIONSHIP WITH SEXUAL STEROID LEVELS AND METABOLIC PARAMETERS”. Gynecol Endocrinol 2018;34:120-124.

Wolfsdorf JI, Glaser N, Agus M, Fritsch M, Hanas R, Rewers A, Sperling MA, Codner E.
“ISPAD CLINICAL PRACTICE CONSENSUS GUIDELINES 2018: DIABETIC KETOACIDOSIS AND THE HYPERGLYCEMIC HYPEROSMOLAR STATE”. Pediatr Diabetes 2018;19 Suppl 27:155-177.

Lourdes Ibáñez, Sharon E. Oberfield, Selma F. Witchel, Richard J. Auchus, R. Jeffrey Chang, Ethel Codner, Preeti Dabadghao, Feyza Darendeliler, Nancy Samir, Elbarbary Alessandra Gambineri, Cecilia Garcia Rudaz, Kathleen M. Hoeger, Abel López-Bermejo, Ken Ong, Alexia S. Peña, Thomas Reinehr, Nicola Santoro, Manuel Tena, Sempere, Rachel Tao, Bulent O. Yildiz, Haya Alkhayyat, Asma Deeb, Dipesalema Joel, Reiko Horikawa, Francis de Zegher, Peter A. Lee “AN INTERNATIONAL CONSORTIUM UPDATE: PATHOPHYSIOLOGY, DIAGNOSIS, AND TREATMENT OF POLYCYSTIC OVARIAN SYNDROME IN ADOLESCENCE” Horm Res Paediatr 2017;Vol.:371–395

Abril Salinas, Ethel Codner “SOP EN LA ADOLESCENTE Y DIAGNOSTICO DIFERENCIAL ¿CUÁNDO DERIVAR?”Boletín SOCHEG. Nº2, Pág. 4 – 5. 2017

Paulina Merino, Claudio Villarroel, Cristián Jesam, Patricia López, Ethel Codner “NEW DIAGNOSTIC CRITERIA OF POLYCYSTIC OVARIAN MORPHOLOGY FOR ADOLESCENTS: IMPACT ON PREVALENCE AND HORMONAL PROFILE” Horm Res Paediatr 2017;88:401–407

Luigi Devoto, Ethel Codner, Paulina Kohen, Patricia Lopez “ANTIMÜLLERIAN HORMONE IN TYPE 2 AND GESTATIONAL DIABETES DURING THE SECOND HALF OF PREGNANCY: RELATIONSHIP WITH SEXUAL STEROIDS LEVELS AND METABOLIC PARAMETERS Gynecological Endocrinology

Pamela Apablaza, Néstor Soto, Ethel Codner “DE LA BOMBA DE INSULINA Y EL MONITOREO CONTINUO DE GLUCOSA AL PÁNCREAS ARTIFICIAL” Rev Med Chile 2017; 145: 630-640

2018 – 2022. Función: Co-Investigadora. “Efectos de la modulación selectiva del receptor de estrógenos en la capacidad funcional, función ventricular derecha y metabolismo mitocondrial en la hipertensión arterial pulmonar”. Proyecto FONDECYT Regular Nº1181097.

2017 – 2021. Función: Investigador responsable. “Contraception in type 1 diabetes”. Proyecto FONDECYT Regular 1170895,

2010-2014. Función: Investigador responsable. “Estrogens and Type 1 Diabetes” FONDECYT 1100123,

2013-2016. Función Coinvestigador. “Epigenetics in type 1 diabetes mellitus (t1dm): expression of micrornas in peripheral mononuclear cells of patients with t1dm: impact of vitamin d on apoptosis and inflammation. Fondecyt 1130240.

2013 – 2017. Función: Supervisora. “Ovarian function in postmenarcheal adolescents conceived after assisted reproductive techniques”. Proyecto FONDECYT de Iniciación 11130240.